159 related articles for article (PubMed ID: 27606158)
21. Prognostic Value of Programmed Cell Death 1 Ligand-1 in Patients With Bone and Soft Tissue Sarcomas: A Systemic and Comprehensive Meta-Analysis Based on 3,680 Patients.
Wang F; Yu T; Ma C; Yuan H; Zhang H; Zhang Z
Front Oncol; 2020; 10():749. PubMed ID: 32582532
[No Abstract] [Full Text] [Related]
22. Clinicopathological characteristics of gynecological cancer associated with hypoxia-inducible factor 1α expression: a meta-analysis including 6,612 subjects.
Jin Y; Wang H; Ma X; Liang X; Liu X; Wang Y
PLoS One; 2015; 10(5):e0127229. PubMed ID: 25993275
[TBL] [Abstract][Full Text] [Related]
23. Association of hypoxia-inducible factor 1 expressions with prognosis role as a survival prognostic biomarker in the patients with osteosarcoma: a meta-analysis.
Khojastehnezhad MA; Seyedi SMR; Raoufi F; Asoodeh A
Expert Rev Mol Diagn; 2022 Dec; 22(12):1099-1106. PubMed ID: 36510847
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall.
Nyström H; Jönsson M; Werner-Hartman L; Nilbert M; Carneiro A
J Clin Pathol; 2017 Oct; 70(10):879-885. PubMed ID: 28404817
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
Yang SL; Ren QG; Wen L; Hu JL
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
[TBL] [Abstract][Full Text] [Related]
26. Expression of hypoxia-inducible factor (HIF)-1alpha as a biomarker of outcome in soft-tissue sarcomas.
Shintani K; Matsumine A; Kusuzaki K; Matsubara T; Satonaka H; Wakabayashi T; Hoki Y; Uchida A
Virchows Arch; 2006 Dec; 449(6):673-81. PubMed ID: 17103226
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis.
Zhu Z; Jin Z; Zhang M; Tang Y; Yang G; Yuan X; Yao J; Sun D
Oncotarget; 2017 Aug; 8(35):59570-59580. PubMed ID: 28938660
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-inducible factor-1 expression predicts osteosarcoma patients' survival: a meta-analysis.
Ouyang Y; Li H; Bu J; Li X; Chen Z; Xiao T
Int J Biol Markers; 2016 Jul; 31(3):e229-34. PubMed ID: 27312586
[TBL] [Abstract][Full Text] [Related]
29. Prognosis value of HIF-1α expression in patients with non-small cell lung cancer.
Wang Q; Hu DF; Rui Y; Jiang AB; Liu ZL; Huang LN
Gene; 2014 May; 541(2):69-74. PubMed ID: 24631267
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.
Kubo T; Furuta T; Johan MP; Ochi M
Eur J Cancer; 2016 May; 58():104-11. PubMed ID: 26990930
[TBL] [Abstract][Full Text] [Related]
31. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
32. Protein expression of hypoxia-inducible factor-1 alpha and hepatocellular carcinoma: a systematic review with meta-analysis.
Cao S; Yang S; Wu C; Wang Y; Jiang J; Lu Z
Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):598-603. PubMed ID: 24835771
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome.
Yang QC; Zeng BF; Dong Y; Shi ZM; Jiang ZM; Huang J
Jpn J Clin Oncol; 2007 Feb; 37(2):127-34. PubMed ID: 17237146
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of hypoxic inducible factor expression in non-small cell lung cancer: a meta-analysis.
Li C; Lu HJ; Na FF; Deng L; Xue JX; Wang JW; Wang YQ; Li QL; Lu Y
Asian Pac J Cancer Prev; 2013; 14(6):3607-12. PubMed ID: 23886153
[TBL] [Abstract][Full Text] [Related]
35. The association of HIF-1α expression with clinicopathological significance in prostate cancer: a meta-analysis.
Huang M; Du H; Zhang L; Che H; Liang C
Cancer Manag Res; 2018; 10():2809-2816. PubMed ID: 30174456
[TBL] [Abstract][Full Text] [Related]
36. [Expression of hypoxia-inducible factor 1α is associated with lymph node metastasis in oral squamous cell carcinoma].
Li JN; Feng ZE; Wang L; Wang YX; Guo CB
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):26-32. PubMed ID: 29483718
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible factor-1α expression indicates poor prognosis in myelodysplastic syndromes.
Tong H; Hu C; Zhuang Z; Wang L; Jin J
Leuk Lymphoma; 2012 Dec; 53(12):2412-8. PubMed ID: 22632108
[TBL] [Abstract][Full Text] [Related]
38. [Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity].
Chen Y; Wang CM; Shi YQ; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):899-904. PubMed ID: 23336375
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia inducible factor: a potential prognostic biomarker in oral squamous cell carcinoma.
Qian J; Wenguang X; Zhiyong W; Yuntao Z; Wei H
Tumour Biol; 2016 Aug; 37(8):10815-20. PubMed ID: 26880584
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor.
Fukushima S; Endo M; Matsumoto Y; Fukushi JI; Matsunobu T; Kawaguchi KI; Setsu N; IIda K; Yokoyama N; Nakagawa M; Yahiro K; Oda Y; Iwamoto Y; Nakashima Y
PLoS One; 2017; 12(5):e0178064. PubMed ID: 28558056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
